Fizomed is a pioneering healthcare brand established in the 1990s by a group of Russian researchers dedicated to developing innovative treatments for common illnesses. Since its inception, Fizomed has focused on introducing unique, highly effective medical devices designed to treat conditions such as kidney stones, gallbladder stones, prostatitis, osteochondrosis, and joint disorders. These devices, which include the Paraffin Containing Device, Vezikur, and Prostalong, have undergone rigorous clinical testing and are registered with Russia's Ministry of Health.

Fizomed stands out by addressing the root causes of ailments rather than merely alleviating symptoms, allowing many patients to avoid the need for invasive procedures. The brand’s commitment to safety, simplicity, and efficacy has earned it recognition across Russia, Ukraine, Belarus, and Kazakhstan, with exports reaching countries like Germany and South Africa. Fizomed has received accolades from respected institutions, and its products are frequently featured in leading medical publications. By providing accessible and effective healthcare solutions, Fizomed represents the future of medicine in the 21st century.